Dual Prevention Pill (DPP) for HIV and Pregnancy Prevention

A qualitative formative research study among women and health care providers in Johannesburg, South Africa. The DPP formative study will use focus group discussions and in-depth interviews to understand women’s interest in using a DPP for HIV and pregnancy prevention and gather inputs regarding informational materials needed for DPP introduction, assess DPP acceptability among providers and explore their training needs and recommendations for appropriate service-delivery settings. The study will also inform the implementation plan for the clinical crossover study (with the objective to assess the acceptability of a Dual Prevention Pill (DPP) containing an oral pre-exposure prophylaxis (PrEP) pill and a combined oral contraceptive (COC) pill in a single capsule for pregnancy and HIV prevention) among women.

Latest Update:

15 February 2021

For more about DPP please email

Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.